Hello, Fool! | Login | Signup | My Fool
Dec 5, 2008 10:17 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.
View Ticker Page (IDIX)
Results 1 - 10 of 24 : 123
Recs
rwwine (88.25) Submitted: 9/26/06 1:13 PM : Start Price: $9.57 IDIX Score: -8.26
IDIX first drug, Telbivudine was recently approved in Switzerland for Chronic Hepatitis B. The FDA will announce their decision on Telbivudine in the next few months. IDIX and NVS have applied for other countries around the world for approval. All...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
tenmiles (99.99) Submitted: 1/09/08 12:40 PM : Start Price: $3.24 IDIX Score: -101.89
Forget Novartis, use today's strength to short Idenix at $3.25; techncially well overbought - looking for 15% pullback within two quarters.
cardiacarrest (21.03) Submitted: 9/20/06 3:24 PM : Start Price: $9.65 IDIX Score: -8.50
HCV drug though not very potent, is not toxic and is first in class
Malstryx (99.84) Submitted: 10/06/06 5:30 PM : Start Price: $9.07 IDIX Score: -4.13
Should be getting some news within the next few months, worth holding until then.
darkflame (93.78) Submitted: 4/15/07 6:57 PM : Start Price: $7.26 IDIX Score: 14.97
What company is this ? Well...it's a small biotec company, Novartis owns more than 10% of it and isnt selling any shares. Novartis bought more than 4 million shares of IDIX at a price over 20 dollars per share. What's the price today ? About 7 dollar...
Report this Post Replies: 1 | Reply | Permalink
damshadow (< 20) Submitted: 1/13/07 12:45 PM : Start Price: $9.06 IDIX Score: 0.51
Discovery of new drugs and treatments? Don't see any in the pipeline at this time. Maybe in the future.
zzlangerhans (99.53) Submitted: 12/16/07 9:55 PM : Start Price: $2.49 IDIX Score: -153.80
After the recent restructuring, it is now clear where this company stands. One HIV drug in phase I with no current plan for a phase II trial. One or two HCV drugs in preclinical development, with a history of one massive faceplant in HCV. Also a hist...
golfwineski (71.82) Submitted: 9/08/06 3:05 AM : Start Price: $9.88 IDIX Score: -11.15
mid-stage biotech---good candidate hep B--like it in the $8-9 range which seems to be the latest support level.
giftofgod (65.23) Submitted: 11/05/08 1:29 AM : Start Price: $5.78 IDIX Score: -6.54
Apparently, Novartis owns more than 50% of this, but Novartis is no longer reimbursing this company for the research. Sure, costs are down 50%, but revenues are down 75%. That means an increased loss. It is possible this will come back, but in this e...
awolfson1015 (27.95) Submitted: 6/26/07 7:52 AM : Start Price: $6.72 IDIX Score: 22.51
The company is sitting on a good amount of cash and has a major backer in the form of Novartis (NVS -- owns over 50% of IDIX's shares). Idenix currently sells a Hepatitis B drug and has a Hep C drug in Phase II trials. They are also working on an H...
Terms & Conditions
RSS Headlines
Fool UK